In a study of non-hospitalized participants with COVD-19 confirmed using polymerase chain reaction (PCR), participants were randomly assigned to twice daily orally administered molnupiravir or placebo for 5 days. The primary outcome in the study was hospitalization and/or death from the time of randomization through Day 29. Participants were enrolled and randomized within seven days of COVID-19 symptom onset.

1. What is the data type of the outcome(s) variable in this study? (There may be more than one correct answer.)

A. Categorical - nominal

B. Categorical - ordinal

C. Quantitative - discrete

D. Quantitative - continuous

2. Which scenario below best describes the study design?

A. One group with one outcome (or variable of interest).

B. Two dependent or paired groups with one outcome (or variable of interest).

C. Two independent groups with one outcome (or variable of interest).

D. One group with two outcomes (or two variables of interest).

3. State an appropriate scientific hypothesis.

4. State in words an appropriate null and alternative hypothesis